16.01.2014 Views

Antibiotic Resistance Threats in the United States, 2013 report

Antibiotic Resistance Threats in the United States, 2013 report

Antibiotic Resistance Threats in the United States, 2013 report

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>in</strong> people allergic to penicill<strong>in</strong>, but resistance to macrolides is <strong>in</strong>creas<strong>in</strong>g and has made<br />

<strong>the</strong>m less useful.<br />

Methicill<strong>in</strong>: An antibiotic derived from penicill<strong>in</strong>. It was previously used to treat bacteria<br />

such as Staphylococcus aureus.<br />

Microbiology: The study of microorganisms.<br />

Microorganism: Organisms so small that a microscope is required to see <strong>the</strong>m. This term<br />

<strong>in</strong>cludes bacteria, fungi, parasites, and viruses.<br />

Morbidity: The number of people who are <strong>in</strong>fected with a specified illness <strong>in</strong> a given<br />

time period.<br />

Mortality: The number of people who die <strong>in</strong> a given time from a specified illness.<br />

MRSA: Methicill<strong>in</strong>-resistant Staphylococcus aureus is used to describe any stra<strong>in</strong> of S. aureus<br />

that is resistant to all types of penicill<strong>in</strong> (not just methicill<strong>in</strong>) as well as cephalospor<strong>in</strong>.<br />

Multidrug-resistant (MDR): Microorganisms that are resistant to multiple classes of<br />

antimicrobials. The exact number of drugs that a microorganism is resistant to varies<br />

depend<strong>in</strong>g on <strong>the</strong> <strong>in</strong>fection or pathogen.<br />

NARMS: The National Antimicrobial <strong>Resistance</strong> Monitor<strong>in</strong>g System monitors antimicrobial<br />

resistance <strong>in</strong> foodborne and o<strong>the</strong>r enteric bacteria, <strong>in</strong>clud<strong>in</strong>g Salmonella, Campylobacter,<br />

Shigella, Escherichia coli O157, and Vibrio (non-V. cholerae). NARMS is a collaboration among<br />

CDC, <strong>the</strong> U.S. Food and Drug Adm<strong>in</strong>istration (FDA), <strong>the</strong> U.S. Department of Agriculture<br />

(USDA), and state and local health departments.<br />

Narrow-spectrum antibiotic: An antibiotic that is active aga<strong>in</strong>st a limited range of<br />

bacteria.<br />

NHSN: CDC’s National Healthcare Safety Network is <strong>the</strong> nation’s most widely used<br />

healthcare-associated <strong>in</strong>fection track<strong>in</strong>g system. NHSN provides facilities, states, regions,<br />

and <strong>the</strong> nation with data needed to identify problem areas, measure progress of<br />

prevention efforts, and ultimately elim<strong>in</strong>ate healthcare-associated <strong>in</strong>fections. In addition,<br />

NHSN allows healthcare facilities to track blood safety errors and important healthcare<br />

process measures such as healthcare personnel <strong>in</strong>fluenza vacc<strong>in</strong>e status and <strong>in</strong>fection<br />

control adherence rates.<br />

Outbreak: When a group of people develop <strong>the</strong> same illness around <strong>the</strong> same time,<br />

and <strong>the</strong> number of people affected is higher than normal. Outbreak <strong>in</strong>vestigations are<br />

conducted to identify what exposure <strong>the</strong> affected people had <strong>in</strong> common.<br />

Pan drug-resistance (PDR): <strong>Resistance</strong> to all drugs that would be considered for treatment.<br />

Exact def<strong>in</strong>itions for PDR differ for each bacteria.<br />

Penicill<strong>in</strong>s: A class of antibiotics <strong>in</strong>clud<strong>in</strong>g amoxicill<strong>in</strong>, methicill<strong>in</strong>, piperacill<strong>in</strong> and o<strong>the</strong>r<br />

drugs based on <strong>the</strong> first true antibiotic discovered <strong>in</strong> 1928 by Dr. Alexander Flem<strong>in</strong>g.<br />

Increased resistance has made many types of penicill<strong>in</strong>s less useful.<br />

Pneumonia: An <strong>in</strong>flammatory condition of <strong>the</strong> lungs affect<strong>in</strong>g primarily <strong>the</strong> microscopic air<br />

110

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!